Afficher la notice abrégée

Treatment Strategies and Survival Outcomes in Breast Cancer

dc.contributor.authorCheung, Kwok-Leung*
dc.date.accessioned2021-02-12T06:33:30Z
dc.date.available2021-02-12T06:33:30Z
dc.date.issued2020*
dc.date.submitted2020-06-09 16:38:57*
dc.identifier46062*
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/61309
dc.description.abstractTreatment strategies for breast cancer are wide-ranging and often based on a multi-modality approach, depending on the stage and biology of the tumour and the acceptance and tolerance of the patient. They may include surgery, radiotherapy, and systemic therapy (endocrine therapy, chemotherapy, and targeted therapy). Advances in technologies such as oncoplastic surgery, radiation planning and delivery, and genomics, and the development of novel systemic therapy agents alongside their evaluation in ongoing clinical trials continue to strive for improvements in outcomes. In this Special Issue, we publish a collection of studies looking at all forms of therapeutic strategies for early and advanced breast cancer, focusing on their outcomes, notably survival.*
dc.languageEnglish*
dc.subjectR5-920*
dc.subjectRC31-1245*
dc.subject.classificationthema EDItEUR::M Medicine and Nursingen_US
dc.subject.otherrelative survival*
dc.subject.otheryoung women*
dc.subject.othercancer treatment*
dc.subject.othern/a*
dc.subject.otherfulvestrant*
dc.subject.otherlapatinib*
dc.subject.othertumor biology*
dc.subject.otherantihormone therapy*
dc.subject.othermastectomy*
dc.subject.otheraromatase inhibitors*
dc.subject.otherchemotherapy*
dc.subject.otherserum biomarker*
dc.subject.othercyclin E*
dc.subject.otheranthracycline resistance*
dc.subject.otherzero-inflated Poisson regression model*
dc.subject.otherlymph-node ratio*
dc.subject.otherCHEK2*
dc.subject.othercomparative effectiveness*
dc.subject.otherbreast-conserving therapy*
dc.subject.othertaxane sensitivity*
dc.subject.otherliquid biopsy*
dc.subject.otherHER2 c-erbB2*
dc.subject.othercolorectal cancer*
dc.subject.otherinfiltrating breast cancer*
dc.subject.othersurvival*
dc.subject.otherexercise characteristics*
dc.subject.otherlactate dehydrogenase*
dc.subject.otherbiomarker*
dc.subject.otherbreast cancer survivors*
dc.subject.otherBRCA*
dc.subject.otherdisease-free survival*
dc.subject.otherPIK3CA*
dc.subject.othermetastatic breast cancer*
dc.subject.othercell-free DNA*
dc.subject.otherinvasive breast cancer*
dc.subject.otherradiotherapy*
dc.subject.otherMetformin*
dc.subject.othersocial well-being*
dc.subject.othergene expression*
dc.subject.othercontralateral breast cancer*
dc.subject.otherbasal-like breast cancer*
dc.subject.otherLMK-235*
dc.subject.otherSrc kinase*
dc.subject.otherHER2/neu*
dc.subject.otherLKB1*
dc.subject.otherOlder women*
dc.subject.otherLDH*
dc.subject.othermutation carriers*
dc.subject.otherstage IV*
dc.subject.othermammography screening*
dc.subject.otherNCDB*
dc.subject.othercMet*
dc.subject.otherSEER*
dc.subject.otherpertuzumab*
dc.subject.otherphysical function*
dc.subject.otheroutcome*
dc.subject.otherribociclib*
dc.subject.otherolder patients*
dc.subject.othergeriatric oncology*
dc.subject.othermetastatic*
dc.subject.otheroverdiagnosis*
dc.subject.othernext-generation sequencing*
dc.subject.otherabemaciclib*
dc.subject.otherEndocrine therapy*
dc.subject.othermonitoring metastatic breast cancer*
dc.subject.otherbreast cancer*
dc.subject.othercirculating tumor cells*
dc.subject.otherBreast Cancer*
dc.subject.otherPALB2*
dc.subject.otherhistone deacetylase*
dc.subject.otherprognosis*
dc.subject.otherphysical activity*
dc.subject.othertrastuzumab*
dc.subject.otherductal carcinoma in situ*
dc.subject.othercontralateral prophylactic mastectomy*
dc.subject.otherERCC1*
dc.subject.otherfamily history*
dc.subject.otherT-DM1*
dc.subject.otherATM*
dc.subject.otheradvanced breast cancer*
dc.subject.otherincidence*
dc.subject.otherpalbociclib*
dc.subject.otherHDAC5 inhibitors*
dc.subject.otherAPOBEC3B*
dc.titleTreatment Strategies and Survival Outcomes in Breast Cancer*
dc.typebook
oapen.identifier.doi10.3390/books978-3-03928-759-8*
oapen.relation.isPublishedBy46cabcaa-dd94-4bfe-87b4-55023c1b36d0*
oapen.relation.isbn9783039287598*
oapen.relation.isbn9783039287581*
oapen.pages264*
oapen.edition1st*


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

https://creativecommons.org/licenses/by-nc-nd/4.0/
Excepté là où spécifié autrement, la license de ce document est décrite en tant que https://creativecommons.org/licenses/by-nc-nd/4.0/